Literature DB >> 28652148

Value of upper endoscopic biopsies in predicting medical refractoriness in pediatric patients with ulcerative colitis.

Katrina J Sullivan1, Mike Wei2, Elizabeth Chernetsova3, Soufiane Hallani4, Joseph de Nanassy5, Eric I Benchimol6, David R Mack7, Ahmed Nasr8, Dina El Demellawy9.   

Abstract

Refractory ulcerative colitis (UC) occurs in patients who experience a severe disease manifestation that is unresponsive to medical therapy. The assessment of upper endoscopic microscopic findings and its correlation with refractory UC has not been fully studied in pediatric patients and is the focus of this study. Medical records of UC patients treated at a tertiary pediatric center between 2000 and 2014 were reviewed. Endoscopic biopsies of the upper gastrointestinal (GI) tract of patients meeting a priori inclusion criteria were compared between refractory UC patients and nonrefractory UC patients for active inflammation. Statistically significant differences were determined between groups, and tissues shown to have significant differences were further evaluated for their diagnostic performance. A total of 52 patients were included, 26 in each group. Significant differences were observed in intraepithelial neutrophil infiltration and percentage involvement of crypts/glands for the antrum, body, and duodenal bulb (P ≤ .001, .005, and .01 [intraepithelial neutrophil infiltration] and P = .001, .009, and .015 [% involvement], respectively). Microabscesses of mucosal glands/crypts were also experienced in a greater number of refractory UC patients in the stomach (ie, antrum and/or body of stomach; P = .005) and duodenum (ie, duodenum and/or duodenal bulb; P = .023). The sensitivity and specificity of upper GI tissues to predict refractory UC were moderate, with sensitivities ranging from 38% to 67% and specificities ranging from 81% to 100%. Our results suggest that children with refractory UC are more likely to have active inflammation in the upper GI tract, and thus, this may represent a predictor of responsiveness to current medical therapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Histology; Pathology; Refractory colitis; Ulcerative colitis; Upper endoscopy

Mesh:

Substances:

Year:  2017        PMID: 28652148     DOI: 10.1016/j.humpath.2017.06.006

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Granulomatous Upper Gastrointestinal Inflammation in Pediatric Ulcerative Colitis.

Authors:  Karen Queliza; Faith D Ihekweazu; Deborah Schady; Craig Jensen; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-04       Impact factor: 2.839

2.  Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.

Authors:  Murtaza M Tambuwala; Mohammed N Khan; Paul Thompson; Paul A McCarron
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

Review 3.  Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review.

Authors:  Yan Sun; Zhe Zhang; Chang-Qing Zheng; Li-Xuan Sang
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.